Ccl17 - chemokine (C-C motif) ligand 17 Gene

Also Known as Tarc; Abcd-2; Scya17; Scya17l

Species: Mus musculus

Gene Type: protein coding
Gene ID: 20295

Summary

Predicted to enable CCR4 Chemokine Receptor binding activity and chemokine activity. Acts upstream of or within negative regulation of myoblast differentiation. Predicted to be active in extracellular space. Is expressed in Sertoli cell; central nervous system; hemolymphoid system; and retina. Orthologous to human CCL17 (C-C motif chemokine ligand 17). [provided by Alliance of Genome Resources, Apr 2022]

Ccl17 Products (1)

mRNA Protein Name
NM_011332.3 NP_035462.2 C-C motif chemokine 17 precursor

Gene Ontology

  • Biological Process
Biological Process GO Annotation Evidence References Source
acts upstream of or within negative regulation of myoblast differentiation IMP
IMP: Inferred from mutant phenotype
23844157 MGI
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

C-C motif chemokine 17

  • small inducible cytokine subfamily A17

Recombinant Ccl17 Proteins

Cat. No. Product Name Accession Purity
HY-P7293 TARC/CCL17 Protein, Mouse (70a.a) F6R5P4 (A34-P103) ≥ 95%, as determined by reducing SDS-PAGE.
HY-P71891A TARC/CCL17 Protein, Mouse (His) Q9WUZ6 (A24-P93) ≥ 95%, as determined by reducing SDS-PAGE.

Related Agents

  • Clinical Phase
  • Pre-clinical Phase

Clinical Phase

Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Phase
HY-148494 Tivumecirnon Antagonist 99.48% Phase 2
Inhibitory Antibodies (1)
Cat. No. Product Name Effect
Purity Phase
HY-P990982 Denrakibart Inhibitor 98.24% Phase 2

Pre-clinical Phase

Bioactive Molecules (13)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P3982 CKLF1-C19 Chemical 99.11% Unkown
HY-176949 STAT6-IN-10 Inhibitor 98.81% Unkown
HY-181006 TSLP modulator-1 Inhibitor 99.61% Unkown
HY-119050 Anti-inflammatory agent 87 Inhibitor / Unkown
HY-175650 STAT6-IN-9 Inhibitor 98.11% Unkown
HY-182564 ST45177901 Antagonist / Unkown
HY-185073 STAT6-IN-11 Inhibitor / Unkown
HY-185144 CCL17-IN-1 / Unkown
HY-185145 CCL17-IN-2 / Unkown
HY-RS02086 CCL17 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-174766 Human CCL17 mRNA / Unkown
HY-RS16826 Ccl17 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS23268 Ccl17 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
Inhibitory Antibodies (2)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P992474 TAVO101 96.62% Unkown
HY-P992378 HZ-1127 Inhibitor / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Ccl17 NCBI NCBI:6361